rubimaillin has been researched along with 1-hydroxy-2-methylanthraquinone in 1 studies
| Studies (rubimaillin) | Trials (rubimaillin) | Recent Studies (post-2010) (rubimaillin) | Studies (1-hydroxy-2-methylanthraquinone) | Trials (1-hydroxy-2-methylanthraquinone) | Recent Studies (post-2010) (1-hydroxy-2-methylanthraquinone) |
|---|---|---|---|---|---|
| 46 | 0 | 33 | 6 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, TH; Chung, MI; Jou, SJ; Ko, FN; Lin, CN; Teng, CM | 1 |
1 other study(ies) available for rubimaillin and 1-hydroxy-2-methylanthraquinone
| Article | Year |
|---|---|
Antiplatelet constituents of formosan Rubia akane.
Topics: Animals; Arachidonic Acid; Collagen; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mass Spectrometry; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Taiwan; Thrombin | 1994 |